Blueprint Bio Raises $7.5M

Blueprint Bio a developer of biomarker technology for the personalized medicine market, has raised $7.5M from Murrieta-based Forentis Partners. Blueprint Bio has offices in Murrieta, along with Philadelphia and Rochester, MN, at the University of Pennsylvania and the Mayo Clinic. According to Forentis Partners, the funding is the first funding out of its $50M, special purpose venture fund focused on biotechnology, its Forentis Fund. Blueprint Bio is led by Matthew Nunez.